Omron Healthcare, Inc. Sustainability Profile
Omron Healthcare, Inc., a leading name in the healthcare technology sector, is headquartered in the United States and operates extensively across North America, Europe, and Asia. Founded in 1933, the company has established itself as a pioneer in the development of innovative medical devices, particularly in the fields of blood pressure monitoring, diabetes management, and pain relief solutions. Omron's core products, including their advanced blood pressure monitors and nebulisers, are distinguished by their accuracy, user-friendly design, and commitment to improving patient outcomes. With a strong market position, Omron Healthcare has received numerous accolades for its contributions to health technology, solidifying its reputation as a trusted partner in personal health management.
DitchCarbon Score
How does Omron Healthcare, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Omron Healthcare, Inc.'s score of 43 is higher than 69% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Omron Healthcare, Inc., headquartered in the US, currently does not have specific carbon emissions data available for the most recent year. The company is a current subsidiary of OMRON Corporation, which cascades its emissions data and climate commitments down to Omron Healthcare. As part of its parent company's sustainability initiatives, OMRON Corporation has set various reduction targets, although specific details regarding these targets have not been disclosed for Omron Healthcare. The initiatives are aligned with industry standards, including the Science Based Targets initiative (SBTi) and the Carbon Disclosure Project (CDP), both of which are sourced from OMRON Corporation at a cascade level of 1. While Omron Healthcare has not publicly committed to specific reduction targets or detailed its climate pledges, it is part of a broader corporate strategy aimed at reducing carbon emissions and enhancing sustainability practices. The absence of specific emissions data and reduction targets highlights the need for further transparency in their climate commitments.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2014 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|---|---|---|
| Scope 1 | 62,636,000 | - | - | - | 0,000,000 | - | - | - | - |
| Scope 2 | 213,912,000 | - | - | - | 00,000,000 | - | - | - | - |
| Scope 3 | 1,423,059,000 | 0,000,000,000 | - | - | 0,000,000,000 | - | - | 00,000,000,000 | 0,000,000,000 |
How Carbon Intensive is Omron Healthcare, Inc.'s Industry?
How Carbon Intensive is Omron Healthcare, Inc.'s Location?
Omron Healthcare, Inc.'s Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Omron Healthcare, Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
